United States Australia Brazil Canada Germany India Ireland Japan Mexico New Zealand Philippines South Africa United Kingdom
Today's discussion podcast artwork
Science

Today's discussion

by Infinity Peptides
ScienceHealth & Fitness
Share this ranking Is this your show? Claim it
Listen on Apple PodcastsPocket CastsRSS feed

Chart positions today · United States

Not on the United States charts we track today.

If you like Today's discussion, try…

Latest episodes

  • The Science of Muscle-Building Peptides

    October 26, 2026 · 20 min

    The science behind injectable peptides used for muscle growth, breaking them down into basic, better, and advanced categories based on how they affect the pituitary gland and hormone levels. She compares the brain to a DJ at a party, where…

  • KPV Peptide and Chronic Inflammation Science

    October 19, 2026 · 18 min

    Chronic inflammation often occurs when cellular alarm systems become permanently stuck, leading many individuals to seek unverified treatments like the gray market peptide KPV. Derived from a human hormone, KPV functions as a…

  • Decoding Mitochondrial Peptides SS-31

    October 12, 2026 · 23 min

    The transcript examines the anti-aging peptide SS-31, explaining that its effectiveness depends entirely on whether an individual possesses damaged mitochondria with degraded structural fats that the compound can physically repair. While…

  • Tesamorelin: The Sculptor of Visceral Fat and Vitality

    October 5, 2026 · 22 min

    This video transcript features Dr. Ashley Froese, a primary care physician who details the metabolic benefits of the peptide Tesamorelin. The source explains how this substance mimics natural hormones to specifically target and eliminate…

  • MOTS-c: The Mitochondrial Peptide That Could Change How We Think About Aging”

    September 28, 2026 · 22 min

    These sources explore the biological significance and therapeutic potential of MOTS-c, a unique 16-amino acid peptide encoded within the mitochondrial DNA. Often described as an "exercise mimetic," this signaling molecule is naturally…

Show 7 more episodesShow fewer episodes

  • Retatrutide: Beyond Weight Loss to Total Metabolic Reset

    September 21, 2026 · 24 min

    These sources provide a comprehensive overview of Retatrutide, an experimental "triple agonist" peptide that targets three metabolic switches to produce unprecedented weight loss and organ protection. Beyond simply reducing body mass, the…

  • Pinealon: The Science and Hype of Brain Bioregulators

    September 8, 2026 · 21 min

    Pinealon is a three-amino acid synthetic peptide developed in Russia as part of the Khavinson bioregulator family to support the central nervous system. Proponents suggest it may improve cognitive function, regulate circadian rhythms, and…

  • Dulaglutide: The Foundation of Modern Metabolic Medicine

    August 31, 2026 · 21 min

    Dulaglutide, marketed as Trulicity, is a once-weekly injectable medication that revolutionized the management of type 2 diabetes by mimicking the natural GLP-1 hormone. The provided text highlights its role as a precursor to more famous…

  • FOXO4-DRI: The Science and Hype of Senolytic Peptides

    August 24, 2026 · 26 min

    FOXO4-DRI is an experimental peptide categorized as a senolytic, designed to combat aging by selectively eliminating senescent or "zombie" cells that no longer divide. These damaged cells accumulate over time and release inflammatory…

  • Cerebrolysin: Clinical Science and Biohacking Analysis

    August 17, 2026 · 23 min

    Cerebrolysin is a complex biological compound derived from porcine brain tissue that is primarily used to support neurological recovery and cognitive function. Unlike many experimental peptides, this substance has undergone decades of…

  • ADAMAX Peptide: Science, Hype, and Cognitive Potential

    August 10, 2026 · 19 min

    ADAMAX is an experimental nootropic peptide engineered to enhance the properties of its predecessor, Semax, by improving brain penetration and metabolic stability. Proponents in the biohacking community claim it provides superior focus…

  • Survodutide: The Metabolic Power of Dual Receptor Agonism

    August 3, 2026 · 20 min

    The provided text introduces Survodutide, an experimental weight-loss medication being developed by Boehringer Ingelheim and Zealand Pharma. Unlike traditional treatments that only target the GLP-1 receptor, this "twincretin" also…

Full episode archive on Apple Podcasts →

About the show

We will discuss the preclinical trial information on Bpc157 what have we heard what have we experienced, along with where does it come from. ‘RSSVERIFY’